(PRWEB) April 14, 2015

The global oncology information system market is estimated to grow at a CAGR of 8.5% from 2014 to 2019. Although mature markets such as the U.S., the U.K. and Germany hold larger shares in the oncology information system market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 11.5% in the next five years. Factors such as increasing government initiatives for modernization of healthcare infrastructure, growing patient population and rising focus of international and domestic players in the Asia-Pacific region are propelling growth in this market.

Inquiries on This Report @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1721676

Growth of the oncology information system market is driven by factors such as rapidly aging population, rising number of cancer cases and increasing focus on the development of technologically advanced OIS across the globe. However, factors such as high maintenance and service expenses and dearth of healthcare IT professionals are restraining the growth of this market. Moreover, emerging markets (such as China and India), strategic acquisitions and multi-year contracts and agreements offer significant opportunities for growth of the oncology information system market.

In this report, the global oncology information system market has been segmented on the basis of product and services [software (patient information systems and treatment planning systems) and professional services (consulting, implementation, post-sale & maintenance and training)], application (medical, radiation and surgical oncology) and end user (hospitals & physician’s offices, governmental institutions and research centers). The patient information systems segment is estimated to account for the largest share of the global oncology information system market in 2014, followed by the treatment planning systems market. Factors such as new product launches, technological advancements and increasing adoption of OIS for cancer care are stimulating the growth of the patient information systems market.    

Speak to Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=1721676

Geographically, North America (comprising the U.S. and Canada) commands the largest share of 42.8% of the global oncology information system market in 2014, followed by Europe. The North American oncology information system market is primarily driven by various factors such as growth in aging population, high prevalence of cancer cases and high adoption rate of technologically advanced devices in North American countries. However, unfavorable healthcare reforms in the U.S. constraints the growth of the oncology information system market in this region.

The global oncology information system market is highly competitive, with a large number of global and local players. As of 2013, the global oncology information system market was dominated by Elekta AB (Sweden) and Varian Medical Systems, Inc. (U.S.) which together accounted for ~80% of the market. Agreements and partnerships; development of technologically advanced OIS; and strategic acquisitions are major strategies adopted by the market players to achieve growth in the oncology information system market.    

Browse Related Reports:

Radiation Dose Management Market by Product (Dose Tracking, Monitoring and Analytics Software, Consulting Services), by Application (Computed Tomography, Angiography, Fluoroscopy), by End User (Hospitals, Diagnostic Centers) – Global Forecasts to 2020

http://www.marketsandmarkets.com/Market-Reports/radiation-dose-management-market-82326344.html

Veterinary Diagnostics Market by Products (Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging), by Animals (Companion, Food-producing, Dog, Livestock, Poultry, Swine) – Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/operating-room-management-market-175407912.html

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

Contact:

Mr. Rohan

North – Dominion Plaza,

17304, Preston Road,

Suite 800, Dallas, TX 75252

Tel: +1-888-600-6441

Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/healthcareit






Related Chemistry Press Releases

Tags